Switzerland's Roche launches 15-minute coronavirus test
AFP - [email protected]
Published: 2 Sep, 2020 CET.
Updated: Wed 2 Sep 2020 09:39 CET
Swiss pharmaceuticals giant Roche on Tuesday announced it would launch a test that detects the novel coronavirus within 15 minutes at the end of September.
They said the test identifies the SARS-CoV-2 virus that has caused the global pandemic that has so far killed more than 851,000 people worldwide.
It will first be available for countries that recognise the CE mark for products sold in the European Union, but they would be urgently seeking approval from the US Food and Drug Administration (FDA).
READ: Zurich proposes ‘rapid coronavirus testing' in pharmacies to curb rising infections
"At launch, there will be 40 million SARS-CoV-2 Rapid Tests available, per month," a capacity that would more than double by the end of the year, said the company statement.
Roche will launch and distribute the product in partnership with biotech company SD Biosensor Inc.
Comments
See Also
They said the test identifies the SARS-CoV-2 virus that has caused the global pandemic that has so far killed more than 851,000 people worldwide.
It will first be available for countries that recognise the CE mark for products sold in the European Union, but they would be urgently seeking approval from the US Food and Drug Administration (FDA).
READ: Zurich proposes ‘rapid coronavirus testing' in pharmacies to curb rising infections
"At launch, there will be 40 million SARS-CoV-2 Rapid Tests available, per month," a capacity that would more than double by the end of the year, said the company statement.
Roche will launch and distribute the product in partnership with biotech company SD Biosensor Inc.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.